Literature DB >> 24532438

Primary bone marrow Hodgkin lymphoma in an HIV-negative patient.

Bhagirathbhai Dholaria1, Daisy Alapat, Konstantinos Arnaoutakis.   

Abstract

Classical Hodgkin lymphoma has distinct clinicopathological features and shows good response to treatment in most cases. Primary bone marrow-limited Hodgkin lymphoma is uncommon and primarily described in HIV-positive patients. It behaves as a distinct entity with aggressive clinical course and poor response to available treatments. We discuss here a case of Hodgkin lymphoma with isolated involvement of bone marrow in an HIV-negative patient, which was successfully treated with conventional chemotherapy.

Entities:  

Mesh：

Year:  2014        PMID： 24532438     DOI： 10.1007/s12185-014-1532-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  13 in total

Review 1.  HIV-associated primary bone marrow Hodgkin's lymphoma: a distinct entity?

Authors:  Binay K Shah; Seshan Subramaniam; David Peace; Carlos Garcia
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

2.  Isolated bone marrow occurrence of classic Hodgkin's lymphoma in an HIV-negative patient.

Authors:  Maurilio Ponzoni; Fabio Ciceri; Roberto Crocchiolo; Graziana Famoso; Claudio Doglioni
Journal:  Haematologica       Date:  2006-03       Impact factor: 9.941

3.  Age-specific survival after Hodgkin's disease in a population-based cohort (United States).

Authors:  C A Clarke; S L Glaser; A W Prehn
Journal:  Cancer Causes Control       Date:  2001-11       Impact factor: 2.506

4.  Comparison of relative value of bone marrow aspirates and bone marrow trephine biopsies in the diagnosis of solid tumor metastasis and Hodgkin lymphoma: institutional experience and literature review.

Authors:  Farah Moid; Louis DePalma
Journal:  Arch Pathol Lab Med       Date:  2005-04       Impact factor: 5.534

5.  Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.

Authors:  Magid Herida; Murielle Mary-Krause; Régis Kaphan; Jacques Cadranel; Isabelle Poizot-Martin; Christian Rabaud; Nathalie Plaisance; Hervé Tissot-Dupont; François Boue; Jean-Marie Lang; Dominique Costagliola
Journal:  J Clin Oncol       Date:  2003-09-15       Impact factor: 44.544

6.  Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.

Authors:  U Tirelli; D Errante; R Dolcetti; A Gloghini; D Serraino; E Vaccher; S Franceschi; M Boiocchi; A Carbone
Journal:  J Clin Oncol       Date:  1995-07       Impact factor: 44.544

7.  Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography-computed tomography era: a West of Scotland study.

Authors:  Róisín Hamilton; Iain Andrews; Pamela McKay; Mike Leach
Journal:  Leuk Lymphoma       Date:  2013-08-05

Review 8.  HIV-associated Hodgkin lymphoma.

Authors:  Antonino Carbone; Annunziata Gloghini; Diego Serraino; Michele Spina
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

9.  Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors.

Authors:  J M Andrieu; S Roithmann; J M Tourani; R Levy; B Desablens; C le Maignan; J A Gastaut; P Brice; M Raphael; B Taillan
Journal:  Ann Oncol       Date:  1993-09       Impact factor: 32.976

10.  Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines.

Authors:  Richard T Hoppe; Ranjana H Advani; Weiyun Z Ai; Richard F Ambinder; Patricia Aoun; Celeste M Bello; Philip J Bierman; Kristie A Blum; Robert Chen; Bouthaina Dabaja; Ysabel Duron; Andres Forero; Leo I Gordon; Francisco J Hernandez-Ilizaliturri; Ephraim P Hochberg; David G Maloney; David Mansur; Peter M Mauch; Monika Metzger; Joseph O Moore; David Morgan; Craig H Moskowitz; Matthew Poppe; Barbara Pro; Jane N Winter; Joachim Yahalom; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2012-05       Impact factor: 11.908
View more
  4 in total

Review 1.  Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.

Authors:  Keiki Nagaharu; Masahiro Masuya; Yuki Kageyama; Takanori Yamaguchi; Ryugo Ito; Keiki Kawakami; Masafumi Ito; Naoyuki Katayama
Journal:  J Med Case Rep       Date:  2018-05-30

2.  Clinical features and prognostic factors of primary bone marrow lymphoma.

Authors:  Gangjian Wang; Yu Chang; Xiaolong Wu; Xin Li; Ling Li; Lei Zhang; Xiaorui Fu; Zhenchang Sun; Xudong Zhang; Mingzh Zhang
Journal:  Cancer Manag Res       Date:  2019-03-29       Impact factor: 3.989

3.  Successful Treatment for Isolated Bone Marrow Hodgkin Lymphoma in an Human Immunodeficiency Virus (HIV)-Negative Patient.

Authors:  Razan Odeh; Hamza Farhan Hamayel
Journal:  Am J Case Rep       Date:  2022-02-21

4.  Primary Bone Marrow HIV-Associated Hodgkin Lymphoma Complicated by Hemophagocytic Lymphohistiocytosis.

Authors:  Ji Lin; Binsah George
Journal:  Genes (Basel)       Date:  2022-09-08       Impact factor: 4.141
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.